Marius Ardeleanu

9.2k citations

73 papers · 3.5k indexed · 3 hit papers · h-index 21

Impact in

Immunology and Allergy top 0.1%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Dermatology top 0.05%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies

Papers in

Dermatology 65
- Dermatology and Skin Diseases 65
Immunology and Allergy 42
- Allergic Rhinitis and Sensitization 34
- Food Allergy and Anaphylaxis Research 12

Co-authors: Neil M.H. Graham Gianluca Pirozzi Jennifer D. Hamilton Thomas Bieber Emma Guttman‐Yassky Laurent Eckert George D. Yancopoulos Diamant Thaçi
Journals: Journal of Investigative Dermatology (11 papers)Journal of Allergy and Clinical Immunology (9 papers)Journal of the American Academy of Dermatology (7 papers)British Journal of Dermatology (7 papers)American Journal of Clinical Dermatology (5 papers)
Partner nations: United States France Germany

In The Last Decade

Marius Ardeleanu

67 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis 2019 · 231 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 British Journal of Dermatology
2018 Journal of Allergy and Clinical Immunology
2014 New England Journal of Medicine

Peers

Countries citing papers authored by Marius Ardeleanu

Since Specialization

Citations

This map shows the geographic impact of Marius Ardeleanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marius Ardeleanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marius Ardeleanu more than expected).

Fields of papers citing papers by Marius Ardeleanu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marius Ardeleanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marius Ardeleanu. The network helps show where Marius Ardeleanu may publish in the future.

Co-authors

The 25 scholars most cited alongside Marius Ardeleanu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marius Ardeleanu Line = papers co-authored together Marius Ardeleanu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults American Journal of Clinical Dermatology ·Richard G. Langley, Arş. Gör. Sacit Köse, Anna Coleman, Marius Ardeleanu, Ali İhsan DİKER, Akira Ikeuti, Ashish Bansal, Zhen Chen, Ana B. Rossi, Brad Shumel, Faisal A. Khokhar	2025	0
2	One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis Advances in Therapy ·付杰英, Chia‐Yu Chu, Hilde Lapeere, Mariateresa Rossi, Silvia Mariel Ferrucci, 淳中山, Anne‐Claire Fougerousse, Daria Fomina, Gregor Holzer, Jarmila Čelakovská, Mona Al‐Ahmad, Thrasyvoulos Tzellos, 拜发奎, Marius Ardeleanu, 裕治松戸	2024	2
3	51363 Growth Analysis in Children Aged Less Than 12 Years with Moderate-to-Severe Atopic Dermatitis Journal of the American Academy of Dermatology ·Amy S. Paller, Bob Geng, Alan D. Irvine, Elaine C. Siegfried, Michael J. Cork, Michele Ramien, Lawrence F. Eichenfield, Rajan Gupta, Bryan Adams, Marius Ardeleanu, Annie Zhang	2024	1
4	Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study British Journal of Dermatology ·Joseph F. Merola, Albert S. Chiou, Emmanuel During, Antonio Costanzo, Peter Foley, C.T. Shii, سماح محمود إبراهيم, Andreas Pinter, Roni P. Dodiuk‐Gad, Dagmar Simon, M. Tauber, Richard Weller, J Rodríguez, Marius Ardeleanu, 拜发奎, Zafer E. Ozturk	2023	13
5	43740 The Effect of Systemic Treatment on Different Anatomical Regions in Pediatric Patients with Atopic Dermatitis: Real-World Data from PEDISTAD Journal of the American Academy of Dermatology ·Danielle Marcoux, Michele Ramien, Martti Antila, Nelson Augusto Rosário Filho, Lara Wine Lee, Trent Monica, Joel C. Joyce, Rajan Gupta, Marius Ardeleanu, Annie Zhang	2023	0
6	Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study Advances in Therapy ·Piergiacomo Calzavara‐Pinton, Jarmila Čelakovská, Hilde Lapeere, Gregor Holzer, Mona Al‐Ahmad, Chia‐Yu Chu, Silvia Mariel Ferrucci, Yoko Kataoka, Mariateresa Rossi, Daria Fomina, 淳中山, Thrasyvoulos Tzellos, Anne‐Claire Fougerousse, Jiangming Wu, Marius Ardeleanu, Zafer E. Ozturk	2023	3
7	Pharmacokinetics, pharmacodynamics, and exposure–efficacy of dupilumab in adults with atopic dermatitis Clinical and Translational Science ·Mohamed Kamal, John D. Davis, Pavel Kovalenko, S. K. Goyal, Eric L. Simpson, Takeshi Nakahara, Makoto Sugaya, Atsuyuki Igarashi, Marius Ardeleanu, Christine Xu, Kazuhiko Arima	2022	4
8	Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials Journal of the European Academy of Dermatology and Venereology ·Lisa A. Beck, Jonathan I. Silverberg, Eric L. Simpson, Gil Yosipovitch, Laurent Eckert, Isabelle Guillemin, Ahmad Shamsuddin Ahmad, Marius Ardeleanu, Stefan Plaum, Neil M.H. Graham, M. Ruddy, Gianluca Pirozzi, A. Gadkari	2020	9
9	384 Dupilumab provides early and sustained, clinically-meaningful improvements in both adults and adolescents: A post hoc analysis of patients not achieving Investigator’s Global Assessment of 0/1 in phase 3 trials, LIBERTY AD SOLO 1 and 2, and LIBERTY AD ADOL Journal of Investigative Dermatology ·Eric L. Simpson, Lisa A. Beck, Mark Boguniewicz, Z. Chen, Marius Ardeleanu, Ashish Bansal, Debra Sierka	2020	1
10	Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ) Journal of Allergy and Clinical Immunology ·Mark Boguniewicz, Diamant Thaçi, Peter Lio, Thomas Hultsch, Ana B. Rossi, Laurent Eckert, Abhijit Gadkari, Brad Shumel, Qiuyue Chen, Zhen Chen, Marius Ardeleanu	2019	4
11	Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS) British Journal of Dermatology ·Andreas Wollenberg, Lisa A. Beck, Andrew Blauvelt, Eric L. Simpson, Z. Chen, 梦瑶陈, Brad Shumel, Faisal A. Khokhar, Thomas Hultsch, E. Rizova, Ana B. Rossi, Neil M.H. Graham, Gianluca Pirozzi, Yuan Lü, Marius Ardeleanu	2019	91
12	IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis Journal of Investigative Dermatology ·Chris Callewaert, Teruaki Nakatsuji, Rob Knight, Tomasz Kościółek, Alison Vrbanac, Paul F. Kotol, Marius Ardeleanu, Thomas Hultsch, Emma Guttman‐Yassky, Robert Bissonnette, Jonathan I. Silverberg, James G. Krueger, Alan Menter, Neil M.H. Graham, Gianluca Pirozzi, Jennifer D. Hamilton, Richard L. Gallo	2019	158
13	Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials British Journal of Dermatology ·Jonathan I. Silverberg, Eric L. Simpson, Marius Ardeleanu, Diamant Thaçi, S. Barbarot, Jerry Bagel, Z. Chen, Laurent Eckert, J. Chao, Andrew Korotzer, E. Rizova, Ana B. Rossi, Yuan Lü, E. Granz, Thomas Hultsch, Gianluca Pirozzi, Bolanle Akinlade	2019	44
14	Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis American Journal of Clinical Dermatology ·Lawrence F. Eichenfield, Thomas Bieber, Lisa A. Beck, Eric L. Simpson, Diamant Thaçi, Marjolein de Bruin‐Weller, Mette Deleuran, Jonathan I. Silverberg, Carlos Ferrándiz, Regina Fölster‐Holst, Zhen Chen, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, George D. Yancopoulos, Marius Ardeleanu	2019	114
15	161 EUROSTAD Prospective Observational Study: Baseline Characteristics, Atopic Dermatitis Severity, and Patient-Reported Outcomes Journal of Investigative Dermatology ·Marjolein de Bruin‐Weller, Andrew Pink, Annalisa Patrizi, Ana M. Giménez‐Arnau, Tove Agner, Feng Yi-dong, Shyamalie Jayawardena, Marius Ardeleanu, Urs Kerkmann, E. Rizova	2019	1
16	162 Biomarkers CCL17/TARC and Total IgE Do Not Predict Clinical Response to Dupilumab in Atopic Dermatitis (AD): a Post hoc Analysis of Pooled Phase 3 Data (SOLO 1 & 2) Journal of Investigative Dermatology ·Jennifer D. Hamilton, Z. Chen, Eric L. Simpson, Neil M.H. Graham, Claire Clibborn, Montserrat Casares López, Marius Ardeleanu	2019	1
17	489 Dupilumab efficacy in atopic dermatitis in four randomized phase 3 trials (liberty ad solo 1&2, chromos, cafe) Journal of Investigative Dermatology ·Eric L. Simpson, Thomas Bieber, Marjolein de Bruin‐Weller, Andrew Blauvelt, Z. Chen, Marius Ardeleanu, Brad Shumel, Paula Holland, Thomas Hultsch	2018	1
18	251 Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial Journal of Investigative Dermatology ·Lisa A. Beck, Najib Alidrissi, Alesandro, Paula Holland, Heribert Staudinger, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu	2017	1
19	373 Dupilumab improves clinical atopic dermatitis parameters and modulates specific IgEs and Staphylococcus aureus abundance Journal of Investigative Dermatology ·Emma Guttman‐Yassky, Jennifer D. Hamilton, Robert Bissonnette, James G. Krueger, Jonathan I. Silverberg, Alan Menter, Richard L. Gallo, Luis Eduardo Lozada Pérez, Brian N. Swanson, Teruaki Nakatsuji, Gianluca Pirozzi, Neil M.H. Graham, Marius Ardeleanu	2016	3
20	Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis New England Journal of Medicine ·Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, G. Gallitto, Neil Stahl, George D. Yancopoulos, Allen Radin Hit paper breakdown →	2014	1008

About Marius Ardeleanu

Marius Ardeleanu is a scholar working on Dermatology, Immunology and Allergy, Physiology, Rheumatology and Space and Planetary Science, having authored 73 papers that have together received 3.5k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (65 papers), Asthma and respiratory diseases (49 papers), Allergic Rhinitis and Sensitization (34 papers), Urticaria and Related Conditions (19 papers), Food Allergy and Anaphylaxis Research (12 papers), IL-33, ST2, and ILC Pathways (10 papers), Adrenal Hormones and Disorders (5 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Immunology and Allergy (2.3k citations), Dermatology (2.9k citations), Physiology (1.5k citations), Rheumatology (688 citations) and Immunology (565 citations). Marius Ardeleanu has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Neil M.H. Graham, Gianluca Pirozzi, Jennifer D. Hamilton, Thomas Bieber, Emma Guttman‐Yassky, Laurent Eckert, George D. Yancopoulos, Diamant Thaçi, Eric L. Simpson and Mayte Suárez‐Fariñas. Their work appears in journals such as Journal of Investigative Dermatology, Journal of Allergy and Clinical Immunology, Journal of the American Academy of Dermatology, British Journal of Dermatology and American Journal of Clinical Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact